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Background:  Minority  groups  generally  experience  more  disparities  than  whites  in behavioral  healthcare
use.  The  population  of  racial/ethnic  groups  is  growing  faster  than  whites.  Given increased  concerns  of
cannabis  use  (CU)  and  its  associations  with  health  conditions,  we  examined  national  trends  in cannabis
use  disorder  (CUD)  among  adults  aged  ≥18  by race/ethnicity.
Methods:  Data  were  from  the  2005–2013  National  Surveys  on Drug  Use  and  Health  (N  =  340,456).  We
compared  CU  patterns  and  the  conditional  prevalence  of  CUD  among  cannabis  users  by race/ethnicity  to
understand  racial/ethnic  variations  in  CUD.
Results: Approximately  1.5%  of adults  met  criteria  for a  CUD in the  past  year.  Regardless  of  survey year,
cannabis  dependence  was  more  common  than  cannabis  abuse,  representing  66% of  adults  with  a  CUD.
Across  racial/ethnic  groups,  the  prevalence  of cannabis  abuse  and  dependence  remained  stable  during
2005–2013.  In the  total  adult  sample,  the  odds  of weekly  CU,  monthly  CU,  and  cannabis  dependence  were
greater  among  blacks,  native-Americans,  and  mixed-race  adults  than  whites.  Among  cannabis  users,  the
odds of cannabis  abuse  and  dependence  were  greater  among  blacks,  native-Americans,  and  Hispanics
than  whites.  Logistic  regression  controlling  for  age,  sex,  education,  and  survey  year  indicated  an  increased
trend  in  monthly  CU  and weekly  CU  in  the  total  sample  and  among  past-year  cannabis  users.  Younger
age,  male  sex,  and  low  education  were  associated  with  increased  odds  of  cannabis  dependence.
Conclusions:  The  large  sample  provides  robust  information  that  indicates  a need  for  research  to monitor
CUD  and  identify  culturally  appropriate  interventions  especially  for targeting  minority  populations.
© 2016  The  Author(s).  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC. Introduction
Heavy or chronic cannabis use (CU) is associated with a wide
ange of health-related conditions, such as motor vehicle injuries,
ognitive impairment, chronic bronchitis symptoms, cardiovascu-
ar diseases, or psychotic symptoms, that can result in healthcare
se (Jouanjus et al., 2014; Volkow et al., 2014). Cannabis use dis-
rder (CUD) is the most prevalent illicit drug use disorder in the
nited States. An estimated 4.2 million Americans aged ≥12 years
ad a CUD in the past year–representing an estimated 59% of indi-
iduals aged ≥12 years with a past-year illicit drug use disorder
Center for Behavioral Health Statistics and Quality (CBHSQ), 2015).
∗ Corresponding author at: Department of Psychiatry and Behavioral Sciences,
uke University School of Medicine, Duke University Medical Center, Box 3903,
urham, NC 27710, USA.
E-mail address: litzy.wu@duke.edu (L.-T. Wu).
ttp://dx.doi.org/10.1016/j.drugalcdep.2016.06.002
376-8716/© 2016 The Author(s). Published by Elsevier Ireland Ltd. This is an open acces
c-nd/4.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
To date, 24 states and Washington DC have medical cannabis,
four states have legalized recreational CU, and another six states
have legislation pending. As the wave of state-speciﬁc policies on
cannabis legalization continues to spread across the nation, they
could have unintended consequences (e.g., an increase in supply
or use-related problems) with lasting implications for the health
and social systems (Volkow et al., 2014, 2016). This study seeks to
leverage national survey datasets to understand recent/active CUD
among racial/ethnic groups to inform surveillance and intervention
efforts.
Although the causal relationship between cannabis laws and
CU problems is intrinsically difﬁcult to determine, various reports
suggest a pattern of growing CU problems. CU may  impair motor
coordination and driving skills, thereby increasing the risk of
injuries (Institute for Behavior and Health, 2013; Volkow et al.,
2014). Acute cannabis intoxication may  increase motor vehicle
crash risk (Rogeberg and Elvik, 2016). Brady and Li (2014) found a
s article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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igniﬁcant increase in the trend of cannabis-detected fatal injuries
uring 1999–2010, whereas the prevalence of alcohol-detected
njuries remained stable. Additionally, medical cannabis laws were
ssociated with a 10–20% increase in cannabis arrests and CU-
elated treatments, suggesting a possible legalization effect on CU
roblems (Chu, 2014). The total physical availability of medical
annabis through dispensaries and delivery services at the city-
evel also was positively associated with current CU and frequent
se (Freisthler and Gruenewald, 2014). Cities with comparatively
igh levels of medical cannabis availability showed a frequent CU
attern. Likewise, Mair et al. (2015) found that the density of local
annabis dispensaries was positively associated with an increase in
U-related hospitalizations. Moreover, cannabis potency detected
n conﬁscated samples increased steadily from about 3% in the
980s to 12% in 2012 (Volkow et al., 2014). Preliminary data
uggested that the average potency of cannabis seized by law
nforcement increased by a half percentage point on average after
edical cannabis legalization (Sevigny et al., 2014). The increase
n the THC content raises concerns that potential adverse effects
f problem CU, such as addiction, motor-vehicle accidents, or
sychotic symptoms, may  be intensiﬁed (Freeman and Winstock,
015; Monte et al., 2015).
The growing concerns of CU-related problems require the anal-
sis of large samples to monitor the CUD (cannabis abuse or
ependence) prevalence, an indicator for intervention, for adult
acial/ethnic populations. Minority groups in general experience
reater disparities than whites in healthcare use that is related to
oor health (Cook et al., 2010; NCHS, 2012). Minority populations
n the United States are growing at a faster rate than the white
lone population. By 2044, more than half of all Americans will
e members of a minority group, and approximately 80% of the US
opulation will be adults aged ≥18 years (Colby and Ortman, 2015).
reviously, Compton et al. (2004) examined DSM-IV CUD among
dults aged ≥18 in the National Longitudinal Alcohol Epidemio-
ogic Survey and the National Epidemiologic Survey on Alcohol and
elated Conditions. They found a signiﬁcant increase in the CUD
revalence between 1991 and 1992 and 2001–2002 among blacks
0.8% vs. 1.8%) and Hispanics (0.6% vs. 1.2%), but there was  little
hange among whites (1.3% vs. 1.4%). While the reasons for the rise
n CUD among minority groups are unclear, the increase in cannabis
otency, changes in perceived risk of CU, as well as environmental
nd socioeconomic factors (e.g., deleterious effects of acculturation
n drug use, lower education) may  contribute to CUD (Compton
t al., 2004; Sinclair et al., 2013).
The U.S. Treatment Episode Data Set (TEDS) collects substance-
nvolved admissions to treatment facilities that receive public
unding. The recent TEDS report showed that cannabis was  the
ost commonly identiﬁed primary illicit drug for treatment among
lacks (29%), Hispanics (22%), and Asians/Paciﬁc Islanders (21%);
hile the most commonly identiﬁed drug other than alcohol among
hites was opiates (34%), followed by cannabis (12%) (SAMHSA,
015). These drug-involved treatment data suggest that CUD may
isproportionally affect minority groups. TEDS data reﬂect treat-
ent admission encounters that can be inﬂuenced by the frequency
f multiple encounters. Individual-level data thus are needed to
etter understand the prevalence of CUD among the growing
acial/ethnic populations to inform research and clinical efforts
n screening, intervention and referral to treatment for CUD. The
ational Survey on Drug Use and Health (NSDUH) provides the
rimary source of ongoing CUD data. The independent and cross-
ectional 2005–2013 NSDUHs use similar designs to allow the
nalysis of the same variables from the pooled sample. The large
ample of NSDUH also permits analysis to produce reliable CUD
stimates for racial/ethnic groups with a smaller population size in
he United States and to distinguish between cannabis abuse and
ependence to estimate the level of CUD for racial/ethnic groups.endence 165 (2016) 181–190
We  examined yearly variations in the past-year CUD prevalence
(abuse, dependence) in the total adult sample and the conditional
CUD prevalence among past-year cannabis users to gauge the
population-level CUD prevalence and determine the likelihood of
CUD given use by race/ethnicity. The latter provides information to
inform prevention and intervention research. In the pooled sam-
ple, we determined racial/ethnic differences in the frequency of CU
(monthly, weekly), cannabis abuse, and cannabis dependence to
clarify CU patterns by race/ethnicity.
2. Methods
2.1. Data source
We  analyzed adult samples (aged ≥18 years) of public-use
datasets from the 2005–2013 NSDUHs to characterize national
trends in CUD by race/ethnicity. We  used the 2005–2013 NSDUH
datasets (n = 36,965–39,133/year), as they used similar designs to
allow analysis of the same variables to study CUD (SAMHSA, 2014).
NSDUH is the primary national survey designed to provide ongoing
estimates of drug use and drug use disorders in the United States
(SAMHSA, 2006, 2014). It used multistage area probability sampling
methods to select a representative sample of the civilian, nonin-
stitutionalized population aged ≥12 years. The sample included
residents of households (including shelters, rooming houses, and
group homes) from the 50 states and civilians residing on military
bases.
Data collection of NSDUH assessments was  conducted at the
respondent’s home for about an hour. Study procedures and pri-
vacy protections were carefully explained, and respondents were
assured that their names would not be recorded and their responses
would be kept strictly conﬁdential. Respondents’ demographics
were assessed by computer-assisted personal interviews. Sub-
stance use and health-related questions were assessed by an audio
computer-assisted self-interviewing (ACASI) method to increase
honest reports of sensitive behaviors (Turner et al., 1998). The
ACASI allowed respondents to either read the questions on a com-
puter screen or listen to the questions read aloud by the computer
through headphones, and then entered their responses directly into
the computer. Weighted response rates of household screening and
interviewing for these years were 84–91% and 72–76%, respectively
(SAMHSA, 2006, 2014).
2.2. Study variables
2.2.1. Demographics. NSDUH deﬁned seven mutually exclusive
groups based on respondents’ self-reported race and eth-
nicity: non-Hispanic white, non-Hispanic black, non-Hispanic
native-American (American Indian/Alaska-native), non-Hispanic
native-Hawaiian/Paciﬁc-Islander, non-Hispanic Asian-American,
mixed-race (>1 race), and Hispanic. The public-use data did not dis-
tinguish between speciﬁc racial groups of mixed-race individuals.
The US census data estimated that 83% of mixed-race individuals
were white in combination with ≥1 other race (black, Asian-
American, native-Hawaiian/Paciﬁc-Islander, native-American, or
other) (US Census Bureau, 2011). We  examined respondents’ age
group, sex, and educational level to describe their key demo-
graphic and to include them as control variables in the analysis of
racial/ethnic differences in CU and CUD due their association with
drug use (Hasin and Grant, 2016). Survey year also was  included as
a covariate.2.2.2. CU and CUD. CU was  deﬁned as any self-reported illicit
(nonmedical) use of cannabis/hashish. Respondents were read the
following: “Marijuana is also called pot or grass. Marijuana is usually
smoked—either in cigarettes called joints or in a pipe. It is sometimes
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Table 1
Demographic characteristics of adults aged 18 years or older: 2005–2013 NSDUH.
Race/ethnicity Sample
size, unweighted
Overall N = 340,456 White n = 216,924 Black n = 41,996 Native-American
n = 5022
Native- Hawaiian/
Paciﬁc- Islander
n = 1699
Asian-American
n = 12,844
Mixed-Race n = 9218 Hispanic n = 52,753
Weighted% % (SE) % 95% CI % 95% CI % 95% CI % 95% CI % 95% CI % 95% CI % 95% CI
Age in years
18–25 14.76 (0.10) 12.93 12.71–13.16 17.96 17.51–18.42 18.28 16.76–19.90 19.23 17.11–21.55 15.56 14.74–16.41 19.23 18.07–20.44 20.18 19.63–20.73
26–34  15.84 (0.10) 13.72 13.49–13.96 17.38 16.76–18.02 16.73 14.46–19.27 19.31 16.90–21.98 20.91 19.77–22.09 16.09 14.62–17.69 23.12 22.39–23.87
35–49  27.83 (0.14) 26.66 26.33–26.98 29.11 28.38–29.85 26.91 24.42–29.56 33.37 29.08–37.95 32.29 30.65–33.98 23.39 21.47–25.42 31.31 30.65–31.99
50+  41.58 (0.20) 46.69 46.21–47.17 35.55 34.55–36.55 38.08 34.56–41.73 28.09 23.37–33.34 31.24 29.57–32.97 41.29 38.23–44.43 25.39 24.54–26.25
Sex
Male  48.22 (0.14) 48.38 48.04–48.73 44.76 43.88–45.64 46.47 43.56–49.40 49.26 43.95–54.58 46.86 45.04–48.68 47.22 44.40–50.06 50.86 50.05–51.67
Female  51.78 (0.14) 51.62 51.27–51.96 55.24 54.36–56.12 53.53 50.60–56.44 50.74 45.42–56.05 53.14 51.32–54.96 52.78 49.94–55.60 49.14 48.33–49.95
Education
<high  school 15.16 (0.13) 10.72 10.46–10.99 19.16 18.25–20.10 25.30 22.31–28.55 13.32 10.52–16.72 6.54 5.66–7.54 16.47 14.71–18.39 36.00 35.12–36.90
High  school 30.60 (0.17) 31.07 30.63–31.51 35.41 34.48–36.35 37.36 33.62–41.26 34.10 29.91–38.55 15.24 14.00–16.56 30.27 27.92–32.74 29.07 28.39–29.76
Some  college 25.81 (0.12) 26.36 26.06–26.66 28.29 27.52–29.07 27.32 24.14–30.75 30.40 27.23–33.77 22.56 21.15–24.03 32.59 29.95–35.34 21.42 20.81–22.05
≥College  degree 28.42 (0.20) 31.85 31.37–32.34 17.15 16.45–17.86 10.02 7.81–12.77 22.18 18.50–26.36 55.67 53.98–57.34 20.67 18.30–23.26 13.50 12.86–14.17
Cannabis  use
Yes, past year 10.97 (0.08) 11.20 10.99–11.41 13.24 12.74–13.76 15.09 13.03–17.41 12.26 9.56–15.60 4.65 4.10–5.27 18.74 17.26–20.31 9.18 8.85–9.52
Monthly  cannabis use (≥12 days/yr)
Yes 7.52 (0.07) 7.43 7.29–7.58 10.56 10.09–11.05 11.91 10.18–13.89 9.08 6.84–11.96 2.45 2.03–2.95 13.65 12.45–14.95 6.33 6.05–6.62
Weekly  cannabis use (≥52 days/yr)
Yes 5.47 (0.05) 5.36 5.23–5.49 8.06 7.68–8.45 8.80 7.46–10.36 6.20 4.57–8.37 1.68 1.36–2.08 10.31 9.27–11.45 4.53 4.30–4.77
Cannabis  abuse
Yes 0.50 (0.01) 0.46 0.42–0.49 0.78 0.68–0.90 1.13 0.76–1.67 0.39 0.19–0.79 0.20 0.15–0.28 0.74 0.54–1.02 0.55 0.48–0.63
Cannabis  dependence
Yes 0.97 (0.02) 0.86 0.82–0.92 1.63 1.48–1.80 2.08 1.59–2.72 0.91 0.67–1.23 0.44 0.32–0.61 1.77 1.39–2.25 0.98 0.88–1.10
Cannabis  abuse or dependence
Yes 1.47 (0.03) 1.32 1.26–1.38 2.41 2.21–2.63 3.21 2.53–4.06 1.30 0.95–1.77 0.65 0.49–0.84 2.52 2.05–3.08 1.53 1.41–1.67
SE: Standard error, CI: Conﬁdence interval, yr: year.
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Table 2
Racial/ethnic differences in cannabis use and cannabis use disorders among adults aged 18 or older: 2005–2013 NSDUH (n = 340,456).
Adjusted logistic
regression model
Past-year cannabis use
(yes vs. no)
Monthly cannabis use
(≥12 days/year vs. no)
Weekly cannabis use
(≥52 days/year vs. no)
Cannabis abuse vs. no Cannabis dependence
vs. no
Cannabis abuse or
dependence vs. no
Adjusted odds ratio, AOR AOR 95% CI AOR 95% CI AOR 95% CI AOR 95% CI AOR 95% CI AOR 95% CI
Race/ethnicity (vs. white)
Black 0.98 0.93–1.03 1.17 1.11–1.24 1.21 1.14–1.29 1.32 1.11–1.57 1.44 1.30–1.59 1.40 1.27–1.54
Native-American 1.15 0.97–1.36 1.30 1.09–1.54 1.27 1.06–1.51 1.81 1.21–2.69 1.78 1.34–2.36 1.79 1.39–2.30
Native-Hawaiian/Paciﬁc-Islander 0.80 0.59–1.09 0.89 0.64–1.24 0.82 0.59–1.14 0.59 0.30–1.16 0.71 0.53–0.95 0.67 0.49–0.91
Asian-American 0.30 0.27–0.34 0.27 0.23–0.32 0.28 0.22–0.34 0.43 0.31–0.59 0.45 0.33–0.63 0.45 0.34–0.58
Mixed-race 1.57 1.41–1.75 1.64 1.47–1.83 1.65 1.45–1.88 1.28 0.91–1.80 1.58 1.23–2.03 1.48 1.19–1.85
Hispanic 0.51 0.49–0.53 0.51 0.48–0.53 0.49 0.47–0.52 0.69 0.58–0.82 0.66 0.57–0.76 0.67 0.60–0.75
Age  in years (vs. 18–25)
26–34 0.48 0.46–0.50 0.53 0.51–0.55 0.56 0.53–0.59 0.34 0.29–0.39 0.40 0.36–0.45 0.38 0.34–0.42
35–49  0.23 0.22–0.23 0.25 0.24–0.27 0.27 0.25–0.28 0.17 0.15–0.20 0.15 0.13–0.17 0.16 0.14–0.17
50+  0.08 0.08–0.09 0.10 0.09–0.10 0.10 0.10–0.11 0.06 0.04–0.08 0.03 0.02–0.05 0.04 0.04–0.05
Sex  (vs. male)
Female 0.54 0.52–0.55 0.46 0.44–0.48 0.43 0.41–0.45 0.33 0.30–0.38 0.48 0.45–0.51 0.43 0.40–0.45
Education (vs. <high school)
High school 0.88 0.84–0.93 0.80 0.76–0.85 0.80 0.75–0.85 0.63 0.55–0.74 0.73 0.66–0.80 0.69 0.63–0.76
Some  college 0.95 0.90–1.00 0.76 0.72–0.81 0.70 0.66–0.75 0.57 0.49–0.65 0.71 0.65–0.79 0.66 0.61–0.71
≥College degree 0.75 0.70–0.80 0.48 0.45–0.52 0.40 0.37–0.43 0.33 0.27–0.42 0.43 0.38–0.49 0.39 0.35–0.44
Year  (vs. 2005)
2006 0.99 0.93–1.05 1.05 0.97–1.13 0.99 0.91–1.09 1.06 0.86–1.31 1.11 0.95–1.28 1.09 0.96–1.24
2007  0.98 0.91–1.06 1.00 0.93–1.07 0.99 0.91–1.07 1.00 0.80–1.26 1.05 0.89–1.24 1.03 0.90–1.18
2008  1.01 0.94–1.09 1.07 0.98–1.16 1.05 0.95–1.15 1.14 0.94–1.40 1.10 0.94–1.30 1.12 0.99–1.26
2009  1.17 1.09–1.25 1.22 1.13–1.32 1.19 1.08–1.32 1.25 1.01–1.55 1.12 0.94–1.33 1.17 1.02–1.33
2010  1.19 1.12–1.27 1.28 1.19–1.38 1.28 1.17–1.39 1.14 0.93–1.41 1.16 0.94–1.43 1.15 0.97–1.37
2011  1.20 1.12–1.29 1.28 1.18–1.38 1.32 1.21–1.44 1.05 0.85–1.30 1.07 0.89–1.28 1.06 0.92–1.23
2012  1.33 1.25–1.42 1.43 1.33–1.54 1.50 1.38–1.64 1.18 0.95–1.45 1.13 0.95–1.34 1.14 0.99–1.32
2013  1.40 1.31–1.50 1.52 1.41–1.64 1.55 1.41–1.70 0.95 0.75–1.20 1.21 1.01–1.45 1.12 0.98–1.29
CI: Conﬁdence interval. Boldface: P < 0.05.
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ooked in food. Hashish is a form of marijuana that is also called hash.
t is usually smoked in a pipe. Another form of hashish is hash oil.” The
urvey subsequently assessed respondents’ past-year use status,
requency of use, and CUD. Standardized assessments for past-year
annabis-speciﬁc abuse and dependence symptoms were based
n DSM-IV criteria (APA, 2000). Consistent with DSM-IV, cannabis
buse included presence of ≥1 abuse symptom and absence of
ependence, and cannabis dependence included presence of ≥3
ependence symptoms, regardless of the abuse status (APA, 2000).
ased on this hierarchical classiﬁcation, abuse was considered less-
evere than dependence, and any CUD included past-year cannabis
buse or dependence (APA, 2000). To understand use pattern and
UD (Wu  et al., 2012), we examined frequency of CU. We  calcu-
ated the mean number of days using CU in the past year and
xamined different levels of use, including any CU, monthly use
≥12 days/years), and weekly CU (≥52 days/years), to understand
hether racial/ethnic variations in CUD were consistent with CU
atterns.
.3. Data analysis
We  examined distributions of key demographics of the total
dult sample (aged ≥18) and the prevalence of CU and CUD. We
alculated the CUD prevalence in the sample and among past-year
annabis users (conditional probability of CUD given use), respec-
ively, by survey year for each racial/ethnic group. We  conducted
ogistic regression analysis of the total adult sample to deter-
ine racial/ethnic and yearly variations in the prevalence of CU
nd CUD, respectively. Among past-year cannabis users, we exam-
ned racial/ethnic differences in weekly CU, monthly CU, and CUD.
e conducted logistic regression analyses to estimate associations
f race/ethnicity with weekly CU, monthly CU, and CUD among
annabis users, while adjusting for age, sex, education, and survey
ear to lessen for their confounding effects. All analyses took into
ccount the NSDUH’s complex designs, such as weighting and clus-
ering (StataCorp, 2013). All results are weighted except for sample
izes.
. Results
.1. Characteristics of the study sample aged ≥18 years (Table 1)
The total adult sample (N = 340,456) included 31.97% of non-
hites (11.52% Black, 13.87% Hispanic, 6.58% others). Compared
ith whites, all non-white groups had higher proportions of young
dults (<35 years); blacks had a higher proportion of women; and
on-white groups (except for Asian-American) had lower propor-
ions of adults with a college degree .
Overall (annual average), 10.97% of adults used cannabis in the
ast year, 7.52% used cannabis monthly (≥12 days/year), 5.47% used
annabis weekly (≥52 days/year), and 1.47% of adults met  criteria
or a past-year CUD (abuse 0.50%, dependence 0.97%). Compared
ith whites, blacks, native-Americans, and mixed-race adults had
 higher prevalence of CU, monthly CU, weekly CU, and cannabis
buse or dependence, and the prevalence of these variables was
onsistently lower among Asian-Americans.
.2. Trend in the past-year CUD prevalence (Supplementary
ables 1–2):
.2.1. CUD in the sample (Fig. 1a and Supplementary Table 1). Across
acial/ethnic groups, there were little yearly variations in the
revalence of cannabis abuse and dependence during 2005–2013.
egardless of year, cannabis dependence was more common than
buse; blacks, native-Americans, and mixed-race adults tended Ta
b
le
 
3
R
ac
ia
l/
et
h
n
ic
R
ac
e/
et
h
n
i
Sa
m
p
le
 
si
z
u
n
w
ei
gh
W
ei
gh
te
d
 
N
u
m
be
r  
of
ca
n
n
ab
is
p
as
t 
ye
ar
W
ei
gh
te
d
 
M
on
th
ly
 
ca
≥1
2 
d
ay
s
W
ee
kl
y  
ca
n
≥5
2  
d
ay
s
C
an
n
ab
is
 
a
C
an
n
ab
is
 
d
C
an
n
ab
is
 
a
d
ep
en
d
e
C
I:
 
C
on
ﬁ
d
en
c
186
 
L.-T.
 W
u
 et
 al.
 /
 D
rug
 and
 A
lcohol
 D
ependence
 165
 (2016)
 181–190
Table 4
Racial/ethnic differences in cannabis use disorders among past-year cannabis users aged 18 or older: 2005–2013 NSDUH (n = 65,879).
Adjusted logistic regression model Monthly cannabis use
(≥ 12 days/year) vs. no
Weekly cannabis use
(≥ 52 days/year) vs. no
Cannabis abuse vs. no Cannabis dependence
vs. no
Cannabis abuse or
dependence vs. no
Adjusted odds ratio, AOR AOR 95% CI AOR 95% CI AOR 95% CI AOR 95% CI AOR 95% CI
Race/ethnicity (vs. white)
Black 1.70 1.53–1.88 1.44 1.33–1.57 1.39 1.16–1.65 1.56 1.40–1.74 1.50 1.35–1.66
Native-American 1.43 1.11–1.83 1.16 0.93–1.46 1.68 1.11–2.53 1.71 1.24–2.36 1.70 1.29–2.25
Native-Hawaiian/Paciﬁc-Islander 1.36 0.96–1.94 1.03 0.64–1.65 0.74 0.35–1.59 0.88 0.62–1.24 0.83 0.57–1.22
Asian-American 0.65 0.53–0.80 0.70 0.55–0.90 1.14 0.80–1.63 1.18 0.83–1.67 1.17 0.87–1.57
Mixed-race 1.27 1.05–1.54 1.24 1.05–1.47 0.99 0.70–1.42 1.25 0.95–1.63 1.16 0.91–1.48
Hispanic 0.95 0.85–1.05 0.89 0.82–0.98 1.27 1.06–1.51 1.19 1.02–1.39 1.22 1.07–1.38
Age  in years (vs. 18–25)
26–34 1.02 0.95–1.09 1.04 0.98–1.11 0.53 0.45–0.63 0.64 0.57–0.72 0.61 0.55–0.67
35–49  0.96 0.88–1.04 0.94 0.86–1.02 0.50 0.43–0.59 0.44 0.38–0.52 0.46 0.41–0.52
50+  1.02 0.89–1.18 0.99 0.87–1.12 0.44 0.32–0.60 0.26 0.18–0.37 0.32 0.25–0.40
Sex  (vs. male)
Female 0.60 0.57–0.63 0.61 0.58–0.64 0.52 0.45–0.59 0.73 0.68–0.79 0.65 0.61–0.70
Education  (vs. <high school)
High school 0.70 0.64–0.76 0.81 0.74–0.88 0.67 0.57–0.77 0.77 0.69–0.85 0.73 0.66–0.80
Some  college 0.51 0.46–0.56 0.58 0.53–0.63 0.56 0.48–0.65 0.71 0.64–0.78 0.65 0.60–0.71
≥College  degree 0.29 0.27–0.33 0.33 0.29–0.37 0.39 0.31–0.50 0.51 0.44–0.58 0.46 0.40–0.53
Year  (vs. 2005)
2006 1.19 1.05–1.36 1.02 0.90–1.15 1.11 0.89–1.40 1.15 0.98–1.36 1.14 0.98–1.32
2007  1.05 0.93–1.19 1.01 0.91–1.12 1.03 0.81–1.31 1.09 0.90–1.31 1.07 0.91–1.25
2008  1.19 1.01–1.39 1.09 0.97–1.23 1.19 0.95–1.49 1.13 0.96–1.34 1.15 1.01–1.32
2009  1.18 1.03–1.35 1.09 0.96–1.24 1.13 0.91–1.41 1.02 0.85–1.21 1.06 0.92–1.21
2010  1.29 1.16–1.44 1.19 1.06–1.34 1.01 0.80–1.27 1.04 0.82–1.31 1.03 0.85–1.25
2011  1.24 1.10–1.39 1.25 1.13–1.38 0.91 0.72–1.17 0.94 0.76–1.15 0.93 0.78–1.11
2012  1.30 1.17–1.44 1.34 1.20–1.50 0.95 0.76–1.19 0.92 0.77–1.10 0.93 0.80–1.09
2013  1.40 1.25–1.58 1.33 1.16–1.52 0.75 0.59–0.96 0.96 0.79–1.16 0.89 0.76–1.04
CI: Conﬁdence Interval. Boldface: P < 0.05.
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3.3.1. Race/ethnicity. Compared with whites, blacks, native-ig. 1. (a) Past-year prevalence of cannabis abuse and dependence among adults ag
mong  past-year adult cannabis users aged ≥18 years in 2013.
o show a pattern of a higher prevalence of cannabis depen-
ence than whites. In 2013, the CUD prevalence was  higher
mong blacks (2.40%, 95% CI = 1.80–3.21%), native-Americans
4.15%, 95% CI = 2.57–6.63%), and mixed-race adults (3.50%, 95%
I = 2.08–5.83%) than whites (1.30%, 95% CI = 1.11–1.52%) (Fig. 1a).
.2.2. CUD among cannabis users (Fig. 1b and Supplementary Table
).. Overall (annual average), 13.39% of past-year cannabis users
et  criteria for a CUD (4.58% abuse, 8.81% dependence). Cannabis
ependence was consistently more prevalent than abuse. Except
or whites, there were little yearly variations in the prevalence
f cannabis abuse and dependence among cannabis users during
005–2013. The test for yearly trend was signiﬁcant for CUD among
hite cannabis users, suggesting a declining prevalence in abuse
r dependence (P < 0.01). Across years, black and native-American
annabis users showed a pattern of a higher prevalence of cannabis
ependence than white cannabis users. In 2013, the CUD preva-8 years: 2005 vs. 2013. (b) Past-year prevalence of cannabis abuse and dependence
lence among cannabis users was higher among black users (16.82%,
95% CI = 13.14–21.28%) and native-American users (20.40%, 95%
CI = 11.96–32.60%) than white users (10.01%, 95% CI = 8.57–11.66%)
(Fig. 1b).
3.3. Adjusted odds ratio of CU and CUD among adults (Table 2)
To understand racial/ethnic differences in CU and CUD, we con-
ducted logistic regression of any CU, monthly CU, weekly CU,  and
CUD (abuse, dependence, any), respectively, when adjusting for
respondents’ age, sex, education, and survey year.Americans, and mixed-race adults had greater odds of monthly CU,
weekly CU, and cannabis dependence, whereas Asian-Americans
and Hispanics had lower odds of monthly CU, weekly CU, and
cannabis dependence.
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.3.2. Age, sex, and education. For both CU and CUD variables,
ounger age, male sex, and low education were associated with
levated odds of use, abuse, and dependence.
.3.3. Survey year. Compared with the prevalence in 2005, the
dds of any CU, monthly CU, and weekly CU, were elevated dur-
ng 2009–2013. Compared with the prevalence in 2005, the odds
f cannabis dependence was elevated slightly in 2013.
.4. CU patterns among past-year cannabis users aged ≥18 years
Table 3)
Among cannabis users (n = 65,879), blacks (mean = 130.51
ays/year) and mixed-race adults (mean = 133.50 days/year) had
 greater mean number of days using cannabis than whites
mean = 109.27 days/year), and Asian-Americans had a lower
ean days of use (mean = 73.93 days/year) (P < 0.05). Compared
ith white cannabis users (66.35%), more black (79.78%), native-
merican (78.91%), native-Hawaiian/Paciﬁc-Islander (74.03%),
ixed-race (72.88%) cannabis users reported monthly CU, and
ewer Asian-American cannabis users (52.76%) reported monthly
U (P < 0.05). A similar pattern in racial/ethnic variation was
bserved for weekly CU (ranging from 36.16% among Asian-
merican users to 60.84% among black users).
.5. Adjusted odds ratio of CU and CUD among cannabis users
Table 4)
Finally, we conducted logistic regression analyses of CU and CUD
mong cannabis users, while adjusting for age, sex, education, and
urvey year.
.5.1. Race/ethnicity. Among cannabis users, blacks and mixed-
aced adults had greater odds than whites of monthly and weekly
U; native-Americans had greater odds than whites of monthly
U; Asians had lower odds than whites of monthly CU; and native-
mericans, and Hispanics had greater odds of cannabis abuse and
ependence than whites.
.5.2. Age, sex, and education. Younger ages, male sex, and low edu-
ation were associated with elevated odds of cannabis abuse and
ependence, respectively
.5.3. Survey year. Compared with the prevalence in 2005, the odds
f monthly CU and weekly CU among cannabis users were elevated
lightly over time. Compared with the prevalence in 2005, the odds
f cannabis abuse among cannabis users was lowered slightly in
013.
. Discussion
Adults constitute the vast majority of the US population, and
tate-level cannabis legalization laws are applied directly to adults.
roblem CU could affect multiple domains of adults’ lives and
ealth, such as cannabis abuse/dependence symptoms, cannabis-
nvolved car accidents, and cardiovascular conditions as well as
mergency department admissions (Asbridge et al., 2012; Blow
t al., 2011; Thomas et al., 2014). Our CUD estimates from the
ational sample have implications for surveillance of CUD and
linical interventions. We  used the largest samples (N = 340,456)
f adults aged ≥18 years available to study indicators of CU
roblems (abuse, dependence). In the population level, blacks,
ative-Americans, and mixed-race adults on average were more
ikely than whites to have a CUD; and Asian-Americans, native-
awaiians/Paciﬁc-Islanders, and Hispanics were less likely to
ave a CUD. Among cannabis users, blacks, native-Americans,endence 165 (2016) 181–190
and mixed-race adults had the highest prevalence of weekly CU
(range: 55.02–60.84% vs. whites 47.87%). Our results of monthly
and weekly CU were consistent with the CUD patterns that added
support for racial/ethnic differences in CUD. These ﬁndings were
in line with racial/ethnic variations in treatment admissions in the
TEDS (SAMHSA, 2015). Considered jointly, problem CU (abuse or
dependence) may  impact healthcare use or treatment demand.
The ﬁndings of elevated odds of weekly CU and cannabis depen-
dence among mixed-race individuals warrant research to monitor
CU and CUD trends to inform intervention. The mixed-race pop-
ulation, especially children/adolescents, is the fastest growing
population in the United States; and it is projected to increase
from 8 million (2.5%) to 26 million (6.2% of the U.S. population)
between 2014 and 2060, reﬂecting an increase of 228% compared
with an increase of 26% for the single-race population (Colby and
Ortman, 2015). Although there is limited information about sub-
stance use disorders among mixed-race adults, an earlier study
of youth 16–23 found that mixed-race youth had a particularly
higher lifetime prevalence of illicit drug use than blacks and His-
panics (Wu et al., 2006). Recently, mixed-race adolescents were
found to have a lower prevalence than whites of disapproving their
peers’ CU as well as perceiving their parents’ and friends’ disap-
proval of adolescents’ own  CU (Wu  et al., 2015). In addition, low
disapproval of CU was associated with elevated odds of CU,  and
mixed-race adolescents had greater odds than white adolescents
of using CU and having a past-year CUD. Because an individual’s
disapproval of CU or attitudes toward use may  be inﬂuenced by
proximal family/social environments, and that state laws on med-
ical or recreational cannabis may  contribute to lenient CU norms
(Friese and Grube, 2013; Sieving et al., 2000), future research needs
to study whether contextual or community-level factors inﬂu-
ence CU and CUD among mixed-race individuals. The TEDS has
not reported treatment admissions for mixed-race individuals. The
increased potency of cannabis and the fastest growing rate of the
mixed-race population support the need to improve reports of
substance-involved statistics for mixed-race individuals (SAMHSA,
2015).
Consistent with the TEDS data (SAMHSA, 2015), our ﬁndings
reveal a need for research to elucidate factors contributing to CUD
among blacks, such as community-level CU norms and blunt use
(Lipperman-Kreda et al., 2014). Black race is related to an increased
prevalence of blunt smoking, and blunt smoking is positively
associated with cannabis abuse/dependence symptoms (Fairman,
2015; Timberlake, 2013). In addition, native-Americans as a group
have a poor health status and face substantial barriers to timely
healthcare (e.g., low income, low education, high rates of chronic
diseases) (Liao et al., 2011; US Census Bureau, 2014). We  found
that approximately 9% native-American adults reported CU weekly
(≥52 days/year) and 3% had a CUD in the past year. However, the
national survey of household residents may  not fully capture the
CUD prevalence on or near reservations. Descriptive data suggested
that native-Americans were over-represented in the California
medical cannabis patients (Reinarman et al., 2011). The county-
level of medical cannabis cards and residents’ support for cannabis
legalization (community CU norms) may  increase residents’ ease of
access to cannabis, including native-Americans (Friese and Grube,
2013). In-depth research efforts for native-Americans are war-
ranted to inform the development of evidence-based and culturally
appropriate addiction prevention and treatment approaches for
this vulnerable population (Novins et al., 2016).
Finally, women admissions accounted for 27% of cannabis-
involved treatment admissions in the TEDS report (SAMHSA, 2015).
Similarly, we found lower odds of CU and CUD among women
than men. However, women  with a CUD tended to have comor-
bid depressive/anxiety problems, and they might present more
severe cannabis withdrawal systems than men  (Compton et al.,
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004; Herrmann et al., 2015; Khan et al., 2013). Given that cannabis
ithdrawal systems are related to relapse and common outcome
easures in studies of pharmacotherapies for cannabis depen-
ence (Marshall et al., 2014), sex differences in comorbidities and
anifestations of CUD symptoms warrant research to inform sex-
peciﬁc or tailored treatments for CUD.
.1. Limitations and strengths
The NSDUH uses cross-sectional designs to produce national
rug use estimates. Our results reﬂect associations, and they cannot
e applied to about 2% of institutionalized or homeless individu-
ls that are not covered by the survey’s sampling plan. All drug
se estimates are based on self-reports, which may  be inﬂuenced
y recall or reporting errors. The NSDUH also has strengths. One
nique strength is about its use of the same standardized assess-
ents of CUD during the studied years to examine CUD over time.
he NSDUH also implements consistency checks in data manage-
ent to ensure data quality, and develops statistical computation
nd analysis weights to minimize response inconsistency and non-
esponse bias (Gfroerer et al., 2002; Harrison et al., 2007).
. Conclusion
Across the major racial/ethnic groups, we found that the major-
ty of adults with a CUD had cannabis dependence, indicating a
eed for treatment. Screening, intervention, and referral to treat-
ent efforts may  target some groups with elevated odds of CUD,
uch as blacks, native-Americans, and mixed-race adults, as well
s less educated adults. Future work can examine how legalization
ifferentially affects racial/ethnic populations. Adjusted analyses
howed a small increase in cannabis dependence in 2013 vs. 2005
nd indicated an increased trend in monthly CU and weekly CU
n the total adult sample and among cannabis users. The increase
n cannabis potency signiﬁes enhanced harms of chronic CU (e.g.,
ddiction, cannabis-involved fatal accidents) (Freeman and Swift,
016). These ﬁndings from a very large sample reinforce the need
o monitor unintended consequences of cannabis laws, especially
or the faster growing racial/ethnic populations.
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